<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Uhlorn JA</submitter><funding>NIDDK NIH HHS</funding><funding>NHLBI NIH HHS</funding><pagination>e018038</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7955317</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(2)</volume><pubmed_abstract>Background Menopause is associated with an increase in the prevalence and severity of hypertension in women. Although premenopausal females are protected against T cell-dependent immune activation and development of angiotensin II (Ang II) hypertension, this protection is lost in postmenopausal females. Therefore, the current study hypothesized that specific CD4&lt;sup>+&lt;/sup> T cell pathways are regulated by sex hormones and Ang II to mediate progression from premenopausal protection to postmenopausal hypertension. Methods and Results Menopause was induced in C57BL/6 mice via repeated 4-vinylcyclohexene diepoxide injections, while premenopausal females received sesame oil vehicle. A subset of premenopausal mice and all menopausal mice were infused with Ang II for 14 days (Control, Ang II, Me</pubmed_abstract><journal>Journal of the American Heart Association</journal><pubmed_title>CD4&lt;sup>+&lt;/sup> T Cell-Specific Proteomic Pathways Identified in Progression of Hypertension Across Postmenopausal Transition.</pubmed_title><pmcid>PMC7955317</pmcid><funding_grant_id>T32 HL007249</funding_grant_id><funding_grant_id>R01 HL131834</funding_grant_id><funding_grant_id>R01 DK098493</funding_grant_id><pubmed_authors>Moffett C</pubmed_authors><pubmed_authors>Husband NA</pubmed_authors><pubmed_authors>Uhlorn JA</pubmed_authors><pubmed_authors>Lindsey ML</pubmed_authors><pubmed_authors>Langlais PR</pubmed_authors><pubmed_authors>Romero-Aleshire MJ</pubmed_authors><pubmed_authors>Brooks HL</pubmed_authors></additional><is_claimable>false</is_claimable><name>CD4&lt;sup>+&lt;/sup> T Cell-Specific Proteomic Pathways Identified in Progression of Hypertension Across Postmenopausal Transition.</name><description>Background Menopause is associated with an increase in the prevalence and severity of hypertension in women. Although premenopausal females are protected against T cell-dependent immune activation and development of angiotensin II (Ang II) hypertension, this protection is lost in postmenopausal females. Therefore, the current study hypothesized that specific CD4&lt;sup>+&lt;/sup> T cell pathways are regulated by sex hormones and Ang II to mediate progression from premenopausal protection to postmenopausal hypertension. Methods and Results Menopause was induced in C57BL/6 mice via repeated 4-vinylcyclohexene diepoxide injections, while premenopausal females received sesame oil vehicle. A subset of premenopausal mice and all menopausal mice were infused with Ang II for 14 days (Control, Ang II, Me</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jan</publication><modification>2026-04-18T01:04:23.148Z</modification><creation>2024-12-03T16:37:59.056Z</creation></dates><accession>S-EPMC7955317</accession><cross_references><pubmed>33410333</pubmed><doi>10.1161/JAHA.120.018038</doi></cross_references></HashMap>